Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The molecular pathogenesis of corticotroph tumors.

Literature DB >> 10204115

The molecular pathogenesis of corticotroph tumors.

P L Dahia¹, A B Grossman.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1999 PMID： 10204115 DOI： 10.1210/edrv.20.2.0358

Source DB: PubMed Journal: Endocr Rev ISSN： 0163-769X Impact factor: 19.871

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease.

Authors: Mathias Riebold; Christian Kozany; Lee Freiburger; Michael Sattler; Michael Buchfelder; Felix Hausch; Günter K Stalla; Marcelo Paez-Pereda
Journal: Nat Med Date: 2015-02-09 Impact factor: 53.440

2. Immunohistochemical analysis of 11-beta-hydroxysteroid dehydrogenase type 2 and glucocorticoid receptor in subclinical Cushing's disease due to pituitary macroadenoma.

Authors: Takanori Ebisawa; Katsuyoshi Tojo; Naoko Tajima; Masami Kamio; Yutaka Oki; Katsuhiko Ono; Hironobu Sasano
Journal: Endocr Pathol Date: 2008 Impact factor: 3.943

3. Outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for refractory Cushing's disease.

Authors: Alexander D Sherry; Mohamed H Khattab; Mark C Xu; Patrick Kelly; Joshua L Anderson; Guozhen Luo; Andrea L Utz; Lola B Chambless; Anthony J Cmelak; Albert Attia
Journal: Pituitary Date: 2019-12 Impact factor: 4.107

Review 4. The Nelson's syndrome... revisited.

Authors: Guillaume Assié; Hélène Bahurel; Jérôme Bertherat; Michèle Kujas; Paul Legmann; Xavier Bertagna
Journal: Pituitary Date: 2004 Impact factor: 4.107

The molecular pathogenesis of corticotroph tumors.

1. A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease.

2. Immunohistochemical analysis of 11-beta-hydroxysteroid dehydrogenase type 2 and glucocorticoid receptor in subclinical Cushing's disease due to pituitary macroadenoma.

3. Outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for refractory Cushing's disease.

Review 4. The Nelson's syndrome... revisited.

Review 5. Classification of pituitary adenomas.

Review 6. Genesis of pituitary adenomas: state of the art.

7. Retinoic acid prevents experimental Cushing syndrome.

Review 8. Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas.

9. Immunohistochemistry of COUP-TFI: an adjuvant diagnostic tool for the identification of corticotroph microadenomas.

Review 10. Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach.